{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:55:42Z","timestamp":1789217742476,"version":"build-2803163510"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001A"],"award-info":[{"award-number":["2014-18-001A"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001B"],"award-info":[{"award-number":["2014-18-001B"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001C"],"award-info":[{"award-number":["2014-18-001C"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001D"],"award-info":[{"award-number":["2014-18-001D"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001E"],"award-info":[{"award-number":["2014-18-001E"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001F"],"award-info":[{"award-number":["2014-18-001F"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001G"],"award-info":[{"award-number":["2014-18-001G"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-18-001H"],"award-info":[{"award-number":["2014-18-001H"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-04-008"],"award-info":[{"award-number":["2014-04-008"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197350","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T15:01:34Z","timestamp":1529074894000},"page":"e0197350","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2"],"prefix":"10.1371","volume":"13","author":[{"name":"The Synodos for NF2 Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3573-3565","authenticated-orcid":true,"given":"Robert","family":"Allaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve P.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta L.","family":"Beauchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishri O.","family":"Blakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Bott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Carlstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Wade","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Desouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Erdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fernandez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Guinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Gusella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Haggarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2010-4328","authenticated-orcid":true,"given":"Salvatore","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra M.","family":"Petrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Pratap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Sciaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Stemmer-Rachamimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Stuhlmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Talkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-469X","authenticated-orcid":true,"given":"D. Bradley","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon S.","family":"Zawistowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-444-62702-5.00005-6","article-title":"Neurofibromatosis type 2","volume":"132","author":"DG Evans","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","article-title":"Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients","volume":"52","author":"A Hexter","year":"2015","journal-title":"J Med Genet"},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","article-title":"American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008\u20132012","volume":"18","author":"QT Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.18632\/oncotarget.3870","article-title":"Genetic\/molecular alterations of meningiomas and the signaling pathways targeted","volume":"6","author":"P Domingues","year":"2015","journal-title":"Oncotarget"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1227\/NEU.0000000000000264","article-title":"Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes","volume":"74","author":"GW Mallory","year":"2014","journal-title":"Neurosurgery"},{"issue":"Suppl","key":"ref6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3171\/2014.8.GKS141503","article-title":"Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2","volume":"121","author":"S Sun","year":"2014","journal-title":"J Neurosurg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1215\/15228517-2007-027","article-title":"Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature","volume":"9","author":"A Balasubramaniam","year":"2007","journal-title":"Neuro Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molonc.2012.02.004","article-title":"Discovery of small molecule cancer drugs: successes, challenges and opportunities","volume":"6","author":"S Hoelder","year":"2012","journal-title":"Mol Oncol"},{"key":"ref9","first-page":"M29","article-title":"Merlin: the neurofibromatosis 2 tumor suppressor","volume":"1423","author":"JF Gusella","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2007.09.002","article-title":"Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth","volume":"29","author":"MF James","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.18632\/oncotarget.4858","article-title":"A high-throughput kinome screen reveals serum\/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas","volume":"6","author":"RL Beauchamp","year":"2015","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/labinvest.3700307","article-title":"Establishment of a benign meningioma cell line by hTERT-mediated immortalization","volume":"85","author":"S Puttmann","year":"2005","journal-title":"Lab Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2015.125","article-title":"Role of Merlin\/NF2 inactivation in tumor biology","volume":"35","author":"AM Petrilli","year":"2016","journal-title":"Oncogene"},{"key":"ref14","first-page":"471","article-title":"A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2","volume":"6","author":"AM Petrilli","year":"2014","journal-title":"Am J Transl Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"MF James","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","article-title":"Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac","volume":"67","author":"H Morrison","year":"2007","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/neuonc\/noq012","article-title":"ErbB\/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma","volume":"12","author":"S Ammoun","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-3615-1_4","article-title":"Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and Meningioma","volume":"1427","author":"SS Burns","year":"2016","journal-title":"Methods Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddu414","article-title":"A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation","volume":"24","author":"JR Gehlhausen","year":"2015","journal-title":"Hum Mol Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","article-title":"Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2","volume":"14","author":"M Giovannini","year":"2000","journal-title":"Genes Dev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1158\/0008-5472.CAN-07-5849","article-title":"Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma","volume":"68","author":"S Ammoun","year":"2008","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MOO.0b013e3282b97310","article-title":"Molecular studies of vestibular schwannomas: a review","volume":"15","author":"DB Welling","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1541-7786.MCR-11-0425-T","article-title":"Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types","volume":"10","author":"MF James","year":"2012","journal-title":"Mol Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2009.09.017","article-title":"Targeting ERK1\/2 activation and proliferation in human primary schwannoma cells with MEK1\/2 inhibitor AZD6244","volume":"37","author":"S Ammoun","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2015.64.3817","article-title":"Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas","volume":"34","author":"JO Blakeley","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/neuonc\/nou020","article-title":"Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas","volume":"16","author":"A Boin","year":"2014","journal-title":"Neuro Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-12-1888","article-title":"Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth","volume":"73","author":"SS Burns","year":"2013","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1158\/0008-5472.CAN-09-3107","article-title":"Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors","volume":"70","author":"HK Wong","year":"2010","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.4161\/cc.21397","article-title":"Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFbeta signaling and defects in the Hippo signaling cascade","volume":"11","author":"M Fujii","year":"2012","journal-title":"Cell Cycle"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-12-3167","article-title":"Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2","volume":"19","author":"K Tanaka","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/neuonc\/nor072","article-title":"AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas","volume":"13","author":"ML Bush","year":"2011","journal-title":"Neuro Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"MA Karajannis","year":"2012","journal-title":"Neuro Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJMoa0902579","article-title":"Hearing improvement after bevacizumab in patients with neurofibromatosis type 2","volume":"361","author":"SR Plotkin","year":"2009","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/neuonc\/not150","article-title":"Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"16","author":"MA Karajannis","year":"2014","journal-title":"Neuro Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11060-017-2447-3","article-title":"A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas","volume":"133","author":"S Goutagny","year":"2017","journal-title":"J Neurooncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/mao.0b013e31816021f7","article-title":"Phosphatidylinositol 3-kinase\/AKT pathway activation in human vestibular schwannoma","volume":"29","author":"A Jacob","year":"2008","journal-title":"Otol Neurotol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/glia.22391","article-title":"The role of insulin-like growth factors signaling in merlin-deficient human schwannomas","volume":"60","author":"S Ammoun","year":"2012","journal-title":"Glia"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"PK Brastianos","year":"2013","journal-title":"Nat Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/lary.22392","article-title":"Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas","volume":"122","author":"A Jacob","year":"2012","journal-title":"Laryngoscope"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"17991","DOI":"10.18632\/oncotarget.7494","article-title":"Loss of tumor suppressor Merlin results in aberrant activation of Wnt\/beta-catenin signaling in cancer","volume":"7","author":"KA Morrow","year":"2016","journal-title":"Oncotarget"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"VE Clark","year":"2013","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/NEN.0000000000000129","article-title":"Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex","volume":"73","author":"R Koschny","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref43","article-title":"Linear Models with R","author":"JJ Faraway","year":"2009"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/1078-0432.CCR-05-1132","article-title":"Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589","volume":"12","author":"DZ Qian","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1158\/1078-0432.CCR-12-0055","article-title":"Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase activity and phosphatidylinositol 3-kinase signaling","volume":"18","author":"C Qian","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ml900028r","article-title":"Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin","volume":"1","author":"SD Knight","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Y. HY Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"M Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"W Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"W Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.bjc.6604676","article-title":"Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer","volume":"99","author":"Q Chang","year":"2008","journal-title":"Br J Cancer"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"MI Davis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"ref53","first-page":"471","article-title":"SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer","volume":"2","author":"TJ Abrams","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.celrep.2015.03.037","article-title":"Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains","volume":"11","author":"TJ Stuhlmiller","year":"2015","journal-title":"Cell Rep"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2012.02.053","article-title":"Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer","volume":"149","author":"JS Duncan","year":"2012","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"31126","DOI":"10.1038\/srep31126","article-title":"Control of cortex development by ULK4, a rare risk gene for mental disorders including schizophrenia","volume":"6","author":"B Lang","year":"2016","journal-title":"Sci Rep"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrd4175","article-title":"Therapeutic targeting of EPH receptors and their ligands","volume":"13","author":"AW Boyd","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","article-title":"mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling","volume":"1","author":"VS Rodrik-Outmezguine","year":"2011","journal-title":"Cancer Discov"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00401-016-1583-8","article-title":"The importance of nerve microenvironment for schwannoma development","volume":"132","author":"A Schulz","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1021\/acs.jproteome.5b00161","article-title":"Chemical Proteomics Uncovers EPHA2 as a Mechanism of Acquired Resistance to Small Molecule EGFR Kinase Inhibition","volume":"14","author":"H Koch","year":"2015","journal-title":"J Proteome Res"},{"key":"ref61","article-title":"EHP receptor signaling as a novel therapeutic target in NF2-deficient meningioma","author":"SP Angus","year":"2018","journal-title":"Neuro-oncology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/BJ20131152","article-title":"Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases","volume":"457","author":"S Banerjee","year":"2014","journal-title":"Biochem J"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s10637-015-0282-y","article-title":"A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors","volume":"33","author":"SF Jones","year":"2015","journal-title":"Invest New Drugs"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1158\/1078-0432.CCR-11-1536","article-title":"Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays","volume":"17","author":"MG Manfredi","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T20:25:10Z","timestamp":1661459110000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197350"}},"subtitle":[],"editor":[{"given":"Irina V.","family":"Lebedeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197350","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,13]]}}}